【外企在中国——链博系列】美敦力大中华区总裁顾宇韶：中国将成为重要的创新策源地

Core Insights - Medtronic is transforming its strategy in China from being an "innovative technology exporter" to a "local ecosystem builder" by focusing on five interconnected chains: innovation integration, local manufacturing, value co-creation, intelligent services, and collaborative supply chain [1][3] Local Manufacturing - Medtronic has invested in local production capabilities, exemplified by the Mazor XC spinal surgery robot, which is a localized version of its global Mazor X series, showcasing China's ability to produce high-end medical devices [3][4] - The "Genesis Electric Stapler," developed entirely in China, was brought from research to mass production within a year and is now used in over 500 hospitals domestically and has been exported globally [4] Innovation Integration - The Lantern left bundle branch pacing catheter, developed through collaboration with Chinese clinicians, represents a significant innovation that will serve global markets, highlighting China's role in driving global medical advancements [5] - Medtronic's first localized product in neurointervention, the "Mei An Xin" coil, has been designed to meet the needs of Chinese patients and is already implanted in 28 provinces [5] Collaborative Ecosystem - Medtronic's "value co-creation chain" and "collaborative supply chain" strategies are evident in its partnerships, such as the RDN technology for hypertension treatment, which is set to be the first device approved in the U.S., EU, and China simultaneously [6] - The company has developed nearly 7,000 supply chain partners in China, with projected procurement of approximately 5 billion RMB in the fiscal year 2025, emphasizing local supplier integration [6][7] Intelligent Services - Medtronic is establishing a digital healthcare innovation base in Beijing, set to open by the end of 2025, focusing on remote management and intelligent follow-up solutions to enhance the healthcare ecosystem in China [8] - The company's long-term commitment to the Chinese market is reflected in its strategy to foster cooperation and shared progress in medical innovation [9]